Catheter Precision, Inc. (VTAK)
NYSE · Healthcare
Catheter Precision, Inc. Operating Income 2017–2025
Catheter Precision, Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Catheter Precision, Inc. operating income for the quarter ending March 31, 2026 was -2.3 M, a 35.16% decrease year-over-year.
- Catheter Precision, Inc. operating income for the twelve months ending March 31, 2026 was -13.6 M, a 24.52% increase year-over-year.
- Catheter Precision, Inc. annual operating income for 2025 was -21.1 M, a 88.05% increase from 2024.
- Catheter Precision, Inc. annual operating income for 2024 was -11.2 M, a 85.61% decrease from 2023.
- Catheter Precision, Inc. annual operating income for 2023 was -78.1 M, a 189.75% increase from 2022.
- Catheter Precision, Inc. annual operating income for 2022 was -27.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Catheter Precision, Inc. Operating Income — FAQ
Catheter Precision, Inc. (VTAK) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Catheter Precision, Inc.'s operating income?
Catheter Precision, Inc. (VTAK) reported operating income of -$21M for fiscal 2025.
Where can I see VTAK's operating income history?
The chart and table above show Catheter Precision, Inc.'s operating income by year and by quarter, including the growth rate.